Search
X
Have questions or want to find out more? Give us a call!
1-877-APA-5818
Blog
Blog Articles.
- 12 November
Esketamine vs. IV Ketamine: The Psychiatric Guide to TRD Treatment
Across our APA offices in California, many patients with treatment-resistant depression (TRD) are hearing about ketamine and wondering: What’s the difference between IV ketamine and intranasal esketamine SPRAVATO? Which is safer? Which is actually FDA-approved for depression? […]
Read More +
- 04 November
The Advanced Psychiatric Algorithm for APA Treatment-Resistant Depression
When low mood, loss of interest, poor energy, and sleep/appetite changes persist despite trying medications. Is this treatment-resistant depression (TRD)? Below is a psychiatry medication-first roadmap we use across our California offices. […]
Read More +
- 31 October
CBT-I Roadmap for Sleep Care From APA in Fairfield, CA
The most reliable way to improve sleep is a structured plan from Advanced Psychiatry Associates: Cognitive Behavioral Therapy for Insomnia (CBT-I) to retrain the sleep system, and smart decisions about medications […]
Read More +
- 30 October
APA Psychiatric Protocol for Treating ADHD and Anxiety Comorbidity
When ADHD and anxiety show up together, the most effective path is medical psychiatric care that sequences diagnosis and medications carefully, monitors safety, and adjusts based on objective outcomes, not guesswork. […]
Read More +
- 30 October
Esketamine Is The Psychiatric Protocol for Treatment-Resistant Depression
When depression keeps returning after multiple medications, treatment decisions can feel like guesswork. Esketamine (SPRAVATO) offers another path, an in-clinic option designed for adults with treatment-resistant depression (TRD) […]
Read More +
- 30 October